Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2001
10/11/2001CA2403612A1 Improved treatment of neovascularization
10/11/2001CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2403160A1 New combination of a betablocker and a cholesterol-lowering agent
10/11/2001CA2402586A1 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
10/11/2001CA2402078A1 Divided dose therapies with vascular damaging activity
10/11/2001CA2401854A1 Therapeutic combinations of antihypertensive and antiangiogenic agents
10/11/2001CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001CA2368966A1 New derivatives and analogues of galanthamine
10/10/2001EP1142999A1 Novel protein and dna thereof
10/10/2001EP1142903A1 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb 1?
10/10/2001EP1142890A1 Aminopyrazole derivatives
10/10/2001EP1142889A1 Pyrazole derivatives as anti-inflammatory/analgesic agents
10/10/2001EP1142880A1 Benzimidazole derivatives
10/10/2001EP1142878A2 Pharmaceutical compositions comprising moexipril magnesium
10/10/2001EP1142875A1 Cinnamamide derivatives and drug compositions containing the same
10/10/2001EP1142870A1 Novel ligands of nuclear receptor
10/10/2001EP1142590A1 Gene therapy for diabetic ischemic disease
10/10/2001EP1142586A1 Inhibitors against vascular lipid deposition containing chymase-inhibiting substances
10/10/2001EP1141728A1 Kidney disease detection and treatment
10/10/2001EP1141342A2 Use of plus-strand synthesis elements in retroviral vectors
10/10/2001EP1141332A1 Human cyclic nucleotide pdes
10/10/2001EP1141296A2 Interferon-epsilon
10/10/2001EP1141293A2 Vascular endothelial growth factor-x
10/10/2001EP1141288A2 Lymphocytic membrane proteins
10/10/2001EP1141287A1 Pancreatic polypeptide zsig66
10/10/2001EP1141278A2 Therapeutic phosphodiesterase inhibitors
10/10/2001EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy
10/10/2001EP1141266A2 Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereof
10/10/2001EP1141251A1 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders
10/10/2001EP1141241A2 Astrocytes, their preparation and uses thereof
10/10/2001EP1141240A1 Use of cd40 engagement to alter t cell receptor usage
10/10/2001EP1141020A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/10/2001EP1141018A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension
10/10/2001EP1141015A1 Insulin-like growth factor (igf) i mutant variants
10/10/2001EP1141014A1 Insulin-like growth factor (igf) i mutant variants
10/10/2001EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response
10/10/2001EP1141003A1 Methods
10/10/2001EP1140989A1 Alpha(v) beta(6) integrin inhibitors
10/10/2001EP1140984A1 Selective inhibitors of mmp-12
10/10/2001EP1140981A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions
10/10/2001EP1140969A1 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140964A2 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140946A2 Quinoline derivatives
10/10/2001EP1140945A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
10/10/2001EP1140941A1 Nitrogen containing heterobicycles as factor xa inhibitors
10/10/2001EP1140939A1 Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-alpha]pyrimidines, and related pharmaceutical compositions and methods
10/10/2001EP1140938A2 High affinity inhibitors for target validation and uses thereof
10/10/2001EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases
10/10/2001EP1140933A2 Process for preparing n6-substituted deaza-adenosine derivatives
10/10/2001EP1140931A1 5ht1 antagonists for antidepressant therapy
10/10/2001EP1140927A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists
10/10/2001EP1140923A1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
10/10/2001EP1140918A1 Thrombin inhibitors
10/10/2001EP1140917A1 S-oxide lipid lowering compounds
10/10/2001EP1140916A1 Heteroaryl-cyclic acetals
10/10/2001EP1140908A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140907A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140906A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
10/10/2001EP1140903A1 Aromatic amides
10/10/2001EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
10/10/2001EP1140900A2 Pyrazole compounds and uses thereof
10/10/2001EP1140898A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
10/10/2001EP1140895A2 Thiopyran compounds as inhibitors of mmp
10/10/2001EP1140893A1 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
10/10/2001EP1140891A1 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments
10/10/2001EP1140881A1 Antithrombotic amides
10/10/2001EP1140880A1 Homopiperazine derivatives as selective emopamil inhibitors
10/10/2001EP1140877A1 Hypolipidemic and antioxidant morpholine derivatives
10/10/2001EP1140876A1 Morpholinone and morpholine derivatives and uses thereof
10/10/2001EP1140871A1 Thrombin or factor xa inhibitors
10/10/2001EP1140867A1 New beta-amide and beta-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists
10/10/2001EP1140862A1 THROMBIN OR FACTOR Xa INHIBITORS
10/10/2001EP1140861A1 Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140852A1 1,2,3,4-tetrahydronaphthalenes and their pharamaceutical use
10/10/2001EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140825A1 Melatonin derivatives and medicine containing same
10/10/2001EP1140823A1 Glucagon antagonists/inverse agonists
10/10/2001EP1140810A1 Benzenic sulphonamide derivatives and their uses
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140792A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
10/10/2001EP1140784A2 Ion channel modulating agents
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140745A1 Colchinol derivatives as vascular damaging agents
10/10/2001EP1140289A1 Method for prevention and treatment of cancer and other cell proliferative diseases with ultrasonic energy
10/10/2001EP1140273A2 Device for locally delivering a drug in a body cavity
10/10/2001EP1140208A1 Pharmaceutical compositions comprising immortalised endothelial cells
10/10/2001EP1140204A2 Vitronectin receptor antagonist pharmaceuticals
10/10/2001EP1140199A1 Hyaluronate lyase used for promoting penetration in topical agents
10/10/2001EP1140191A1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
10/10/2001EP1140190A1 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
10/10/2001EP1140189A1 Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
10/10/2001EP1140188A1 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
10/10/2001EP1140187A1 Combinations for cardiovascular indications
10/10/2001EP1140186A1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
10/10/2001EP1140185A1 Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
10/10/2001EP1140184A1 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
10/10/2001EP1140176A1 Transcutaneous photodynamic treatment of targeted cells
1 ... 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 ... 1595